Skip to main content

Day: June 28, 2022

Achiko AG – Suspension of Trading

ZURICH, Switzerland, June 28, 2022 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that it has received notification from SIX Exchange Regulation AG (“SER”) that the trading of Achiko’s shares shall be suspended as of Tuesday, June 28, 2022. On June 27, 2022, SER has performed an initial review of Achiko’s annual financial statements published on June 26, 2022 and determined that they do not comply with Art.49 and Art. 51 of the Listing Rules1 (“LR”) requiring the Issuer to publish an annual financial report, comprising the audited annual financial statements in accordance with the applicable financial reporting standard, as well as the corresponding audit report. SER noted that the audit report included in the annual report...

Continue reading

Industrial Plants Are Inspected by Skypersonic Drone Piloted From Across the Atlantic Ocean Via Cellphone Connection – A World First

Skypersonic’s Trans-Atlantic Inspection of Iren Utility Plant in Italy Portends Era of Quick, Safe and Cost-Effective Inspections of Industrial Facilities Across the Globe ORLANDO, Fla. and TURIN, Italy, June 28, 2022 (GLOBE NEWSWIRE) — Relying only on an internet connection from a normal cellphone, industrial drone company Skypersonic — part of publicly traded drone company Red Cat Holdings (NASDAQ: RCAT) — visually inspected the interior of a fully operational utility plant in Turin, Italy, using a drone controlled from Orlando, Fla., 4,800 miles away. To see a video of this historic transoceanic remote flight, click here: https://www.youtube.com/watch?v=cq8ftbUyBu8. The Orlando-based pilot — Drew Camden, president of Red Cat subsidiary Rotor Riot — had no advance knowledge of the Iren district heating-network plant in Turin...

Continue reading

Graybug Announces Review of Strategic Alternatives

BALTIMORE, June 28, 2022 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced that its Board of Directors will conduct a comprehensive review of strategic alternatives focused on maximizing shareholder value. As part of this process, the Company will explore the potential for an acquisition, company sale, merger, divestiture of assets, private placement of equity securities, or other strategic transactions. As of March 31, 2022, the company’s cash, cash equivalents, and short-term investments totaled $55.3 million. Graybug has retained Piper Sandler Companies to act as its financial advisor to assist with this review process. “The goal of this strategic evaluation process is to ensure...

Continue reading

Triterras Reports Financial Results for Fiscal Year Ended February 28, 2022

SINGAPORE, June 28, 2022 (GLOBE NEWSWIRE) — Triterras Inc. (OTC Expert Market: TRIRF) (“Triterras” or the “Company”), a leading fintech company focused on trade and trade finance, today reported its audited financial results for the fiscal year ended February 28, 2022. “Our results for the fiscal year ended February 28, 2022 demonstrate the performance of our business despite the difficult operating conditions for the Company, the trade and supply chain finance industry created by COVID-19 and the related global supply chain constraints,” said Triterras’ Chairman and CEO Srinivas Koneru. “We benefited from our participation in the Marketplace sub-module to generate trade marketplace revenue to which we grew revenue year-over-year despite the industrywide headwinds, as our differentiated and blockchain-enabled KratosTM platform...

Continue reading

Synlogic to Present at the 2022 National PKU Alliance (NPKUA) Conference

VANCOUVER, Wash., June 28, 2022 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, announced today it will participate at the National PKU Alliance’s (NPKUA) biennial conference July 7-10, 2022 in Vancouver, Washington. As an event sponsor, Synlogic has been invited to present during the session “What’s New in PKU? (Emerging Therapies, Research, Foods & Beyond).” In addition, the team will share data on dietary protein intake in PKU patients during a poster presentation. Presentation:Title: Transforming Medicine through Synthetic Biology Presenter: Dr. Marja Puurunen, MD, Ph.D, Therapeutic Area Lead, Executive Medical Director Date and Time: Friday, July 8, 2022; 3:30...

Continue reading

Fate Therapeutics Announces Expansion of Solid Tumor Collaboration with ONO Pharmaceutical for Off-the-Shelf, iPSC-derived CAR NK and CAR T-Cell Cancer Immunotherapies

ONO to Contribute Novel Binding Domains for a Second Solid Tumor Antigen to the Collaboration Expanded Partnership Enables Development of both CAR NK and CAR T-cell Collaboration Candidates for Solid Tumors SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that it has expanded its off-the-shelf, iPSC-derived, cell-based cancer immunotherapy collaboration with ONO Pharmaceutical Co., Ltd. (ONO) to include the development of chimeric antigen receptor (CAR) NK cell collaboration candidates. In addition, as part of the collaboration’s expansion, ONO will contribute novel binding domains targeting a second solid tumor antigen. Under the original Collaboration...

Continue reading

Exela Technologies Announces New Logo with L’Assurance Maladie Caisse Nationale, the French National Insurance Fund

PARIS, June 28, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA, XELAP), today announced a contract with L’Assurance Maladie Caisse Nationale (“Cnam”), the French National Insurance Fund, utilizing Exela’s PCH Global platform to speed up the National Agency’s digital transformation. While the initial total contract value (“TCV”) is $2.5 million, the 4-year contract has the potential to grow to over $4.5 million over this period. Initially, the solution will deploy Exela’s cutting-edge Raptor and Intelliscan XDS scanners as well as a full OCR application across multiple sites as part of Exela ITPS (Information and Transaction Processing Solutions) segment. The online classification and extended sorting capacity will handle a wide range of document types and the initial deployment will be rolled out to two...

Continue reading

OTC Markets Group Welcomes Lundin Gold Inc. to OTCQX

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF), a Canadian mining company, has qualified to trade on the OTCQX® Best Market. Lundin Gold Inc. upgraded to OTCQX from the Pink® market. Lundin Gold Inc. begins trading today on OTCQX under the symbol “LUGDF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to...

Continue reading

OTC Markets Group Welcomes Collective Mining Ltd to OTCQX

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Collective Mining Ltd (TSX-V: CNL; OTCQX: CNLMF), an exploration and development company focused on identifying and exploring prospective mineral projects in South America, has qualified to trade on the OTCQX® Best Market. Collective Mining Ltd upgraded to OTCQX from the Pink® market. Collective Mining Ltd begins trading today on OTCQX under the symbol “CNLMF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international...

Continue reading

ValOre Reports Encouraging Trench Results from Tróia Target, Pedra Branca

Figure 1: Tróia Target Plan Map, highlighting trench locations and assays. Figure 1: Tróia Target Plan Map, highlighting trench locations and assays.Figure 2: Photographs from trenching at the Tróia Target, highlighting chromitite reef horizons and chromite-rich ultramafics. Figure 2: Photographs from trenching at the Tróia Target, highlighting chromitite reef horizons and chromite-rich ultramafics.Figure 3a: Trench TR22TR02 cross section, Tróia Target, highlighting geology, assays, and proximal Trado® auger drilling. Figure 3a: Trench TR22TR02 cross section, Tróia Target, highlighting geology, assays, and proximal Trado® auger drilling.Figure 3b: Trench TR22CC01 cross section, Tróia Target, highlighting geology, assays, and proximal Trado® auger drilling. Figure 3b: Trench TR22CC01 cross section, Tróia Target, highlighting geology,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.